Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome
- Conditions
- Rheumatoid ArthritisSystemic Lupus ErythematosusSystemic SclerosisSjögren's SyndromeAnkylosing SpondylitisDry Eye Syndrome
- Registration Number
- NCT03937271
- Lead Sponsor
- Taipei Veterans General Hospital, Taiwan
- Brief Summary
To explore the association among TCM pattern, TCM tongue diagnosis and TCM pulse diagnosis for Autoimmune disease and Dry eye syndrome
- Detailed Description
Objective: To explore the association among TCM pattern, TCM tongue diagnosis and TCM pulse diagnosis for Autoimmune disease and Dry eye syndrome
Method:
This study wants to establish the objective measurement of Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects. And the investigators want to use the objective measurement tools to explore the association of TCM pattern, heart rate variability (HRV), TCM tongue diagnosis and TCM pulse diagnosis among at least 50 each AID group subjects and at least 50 DES subjects.
Expected Results:
1. To evaluate the difference among TCM pattern, HRV, TCM tongue diagnosis, TCM pulse diagnosis for the each AID groups.
2. To evaluate the difference among TCM pattern, HRV, TCM tongue diagnosis, TCM pulse diagnosis for the each DES groups.
3. To evaluate the difference among TCM pattern, HRV, TCM tongue diagnosis, TCM pulse diagnosis among the AID groups and DES group.
Keyword: Autoimmune disease, Dry eye syndrome, TCM pattern, TCM tongue diagnosis, TCM pulse diagnosis
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- (1) aged between 20 and 75 years
- (2) fulfilled the 2002 American-European Consensus Criteria for SS (AECG)
NA
Systemic lupus erythematosus
Inclusion Criteria:
- (1) aged between 20 and 75 years
- (2) fulfilled the 1982 ACR revised Systemic lupus erythematosus criteria Exclusion Criteria: NA
Rheumatoid Arthritis
Inclusion Criteria:
- (1) aged between 20 and 75 years
- (2) fulfilled the 2010 ACR/EULAR Rheumatoid Arthritis classification criteria Exclusion Criteria: NA
Systemic Sclerosis
Inclusion Criteria:
- (1) aged between 20 and 75 years
- (2) fulfilled the 1980 ACR eSystemic Sclerosis criteria Exclusion Criteria: NA
Ankylosing spondylitis
Inclusion Criteria:
- (1) aged between 20 and 75 years
- (2) fulfilled the 1984 Ankylosing spondylitis Modified New York criteria Exclusion Criteria: NA
Dry eye syndrome
Inclusion Criteria:
- (1) aged between 20 and 75 years
- (2) Schirmer's test less than 10 mm/5 min
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TCM tongue diagnosis Five year TCM tongue diagnosis is a tool for detecting tongue expression among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS), and Dry eye syndrome (DES).
TCM pattern Five year TCM pattern is a tool for detecting the constitution among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS), and Dry eye syndrome (DES).
TCM pulse diagnosis Five year TCM pulse diagnosis is a tool for detecting pulse of radial artery among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS), and Dry eye syndrome (DES) .
Heart rate variability (HRV) Five year HRV is a tool for detecting the ratio between High-frequency (HF) activity and low-frequency (LF) activity. among the Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS), and Dry eye syndrome (DES) .
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Ching-Mao Chang
🇨🇳Taipei, Taiwan (r.o.c.), Taiwan
Ching-Mao Chang🇨🇳Taipei, Taiwan (r.o.c.), Taiwan